Register entry
HAS Healthcare Advanced Synthesis SA
- Registered sites
- 1
- Drug products
- 11
- Live patents
- 0
- Countries
- 1
- Base
- Switzerland
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureFinished drug manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| HAS Healthcare Advanced Synthesis SA | BiascaSwitzerland | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3002807151 |
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Anamorelin Hydrochloride | POWDER | BULK INGREDIENT |
| - | Bexarotene | POWDER | BULK INGREDIENT |
| - | Carfilzomib | POWDER, FOR SOLUTION | BULK INGREDIENT |
| - | Crinecerfont | POWDER | BULK INGREDIENT |
| - | Cysteamine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Dantrolene Sodium | POWDER | BULK INGREDIENT |
| - | Glycerol Phenylbutyrate | LIQUID | BULK INGREDIENT |
| - | Glycerol Phenylbutyrate | LIQUID | BULK INGREDIENT |
| - | Isotretinoin | POWDER | BULK INGREDIENT |
| - | Lofexidine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Palonosetron Hydrochloride | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.